Invesco Dorsey Wright Healthcare Momentum ETF
Limited financial coverage for PTH.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Range $53 – $53
Price Chart
About the company
The Invesco Dorsey Wright Healthcare Momentum ETF (PTH) is structured to mirror the performance of the Dorsey Wright Healthcare Technical Leaders Index. This exchange-traded fund typically allocates a minimum of 90% of its total assets to the equities found within this benchmark index. The Index itself is specifically engineered to identify healthcare companies that demonstrate strong "relative strength," which indicates significant momentum.
- IPO
- 2006
- HQ
- Downers Grove, IL, US
Get TickerSpark's AI analysis on PTH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $137.00M
- Div Yield
- 2.59%
- 52W High
- $64.10
- 52W Low
- $44.47
- 50D MA
- $60.88
- 200D MA
- $53.87
- Beta
- 0.97
- RSI (14)
- 43
- Avg Volume
- 59.03K
No earnings-call transcripts are available for PTH yet.
- Free Float
- 0.0%
- Shares Outstanding
- 2.33M
- Float Shares
- 0
of shares held by institutions
63 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Morgan Stanley | 136.55K | ▼ 4.50K |
| Bank Of America Corp | 110.76K | ▼ 2.95K |
| Lpl Financial LLC | 76.82K | ▼ 7.26K |
| Royal Bank Of Canada | 70.83K | ▲ 11.60K |
| Sfi Advisors, LLC | 56.28K | ▼ 1.71K |
| Cambridge Investment Research Advisors, Inc. | 50.20K | ▼ 3.53K |
| Wells Fargo & Company/Mn | 40.02K | ▲ 1.11K |
| Iht Wealth Management, LLC | 38.37K | ▼ 19.52K |
| Wealthbridge Capital Management, LLC | 36.96K | ▲ 36.96K |
| Byrne Financial Freedom, LLC | 32.92K | ▼ 758 |
| Raymond James Financial Inc | 25.95K | ▲ 799 |
| Farther Finance Advisors, LLC | 24.67K | ▼ 136 |
Our PTH coverage
Recent articles, reports, and earnings notes.
No research on PTH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PTH report →Should You Invest in the Invesco Dorsey Wright Healthcare Momentum ETF (PTH)?
zacks.com · Sep 28
Micot Pharma Reports Positive Operating Cash Flow and Advances Late-Stage Pipeline in 1H 2026
gurufocus.com · Aug 31
Entera Bio Phase 2 Data Supporting EB613's (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting
globenewswire.com · Aug 4
Should You Invest in the Invesco Dorsey Wright Healthcare Momentum ETF (PTH)?
zacks.com · Jul 27
Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026
globenewswire.com · Jun 16
Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism
globenewswire.com · Jun 13
5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism
globenewswire.com · Jun 11
Septerna to Present Preclinical Characterization of SEP-479, an Oral PTH1R Agonist for Hypoparathyroidism, at 2026 ENDO Annual Meeting
businesswire.com · Jun 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.